What is RNA and how can we use the body's own RNA editing machinery to treat disease? Learn more about the Axiomer® RNA editing technology and how we are creating a new class of medicines.
ProQR invented an entirely new way to treat genetic diseases. Axiomer enables RNA base editing by recruiting ADAR so your own body can treat disease. Learn more here.
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
… approved RNA therapies being used to treat patients today. Axiomer™ RNA editing technology Axiomer™ RNA editing … RNA oligonucleotides to alter RNA. We call this technology Axiomer™. We believe this technology has the potential to …
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
… An innovative biotech company advancing our proprietary Axiomer RNA-editing platform technology. We are ProQR We are … and common diseases. We focus on advancing our proprietary Axiomer™ RNA-editing platform technology. ProQR has offices …
… treatments for people with rare genetic diseases. Axiomer RNA base editing At ProQR we invented the Axiomer™ technology that enables single base editing to …
